| Trial ID: | L0888 |
| Source ID: | JPRN-UMIN000015727
|
| Associated Drug: |
Ipragliflozin
|
| Title: |
Randomized, controlled trial of the clinical effect of selecrive SGLT2 blocker, ipragliflozin, and DPP-4 blocker in type 2 diabetic patients with NAFLD/NASH.- multicenter study - - Randomized, controlled trial of ipragliflozin and DPP-4 blocker in type 2
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
type 2 diabetic patients with NAFLD/NASH
|
| Interventions: |
dietand ergotherapy and or (alpa-GI, Met) and sugra.<br>diet and ergotherapy and/or (alpa-GI,Met) +DPP-4 blocker.
|
| Outcome Measures: |
Rate of patients decreasing of HbA1c>0.5% and not gaining weight gain 72 weeks after administration.nan
|
| Sponsor/Collaborators: |
Saga University
|
| Gender: |
All
|
| Age: |
20years-old80years-old
|
| Phases: |
Not selected
|
| Enrollment: |
128
|
| Study Type: |
Interventional
|
| Study Designs: |
Parallel Randomized
|
| Start Date: |
24/11/2014
|
| Completion Date: |
30/04/2019
|
| Results First Posted: |
--
|
| Last Update Posted: |
3 December 2019
|
| Locations: |
Japan
|
| URL: |
https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018010
|
